Prosecution Insights
Last updated: April 19, 2026
Application No. 18/248,885

WASTEWATER FOAM CONTROL AGENT

Final Rejection §103§DP
Filed
Apr 13, 2023
Examiner
BREWSTER, HAYDEN R
Art Unit
1779
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Dow Global Technologies LLC
OA Round
2 (Final)
61%
Grant Probability
Moderate
3-4
OA Rounds
3y 6m
To Grant
99%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allow Rate
327 granted / 534 resolved
-3.8% vs TC avg
Strong +50% interview lift
Without
With
+50.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
32 currently pending
Career history
566
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
42.4%
+2.4% vs TC avg
§102
17.9%
-22.1% vs TC avg
§112
31.0%
-9.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 534 resolved cases

Office Action

§103 §DP
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. DETAILED FINAL ACTION Status of Claims Cancelled Currently Amended Previously Presented/Original Pending and Examined 1-4, 7 and 8 5 6 5 and 6 The examined claims are drawn to a method. Status of Previous Objections / Rejections At this juncture, Examiner withdraws the previous Office action’s (OA) (i.e, 06/18/2025) 35 USC §101, §112, §102 and §103 and one of the Double Patenting rejections in view of amendments to the claims, Applicant’s remarks and a reconsideration of the pertinent rejections. However, after careful reconsideration of the claims, Examiner believes new 35 USC 35 USC §103 rejections, are appropriate and has applied such rejections to the noted claims. Response to Amendment In their reply dated August 22, 2025, Applicant amended the claims to positively recite that the foam control agent is added to a wastewater treatment process and to add a silicone into independent claim 5. In view of the claim amendments and the attendant revised scope of the claimed invention, Examiner applies new claim interpretations and grounds of rejections in this OA including a combination of prior art of record. The Double Patenting rejection over claims 5-7 and 9 of copending Application No. 18/248165 was withdrawn in view of claim amendments. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. The inventive entity for a particular application is based on some contribution to at least one of the claims made by each of the named inventors. MPEP §2137.01. Claim 5 and 6 are rejected under 35 U.S.C. 103 as being unpatentable over Abel (US4,341,656) in view of Chen et al. (WO2019177726; APA as US20210000147, referenced below; Chen)(both of record). Regarding claims 5 and 6, Abel discloses a method of controlling foam for wastewater treatment (Abstract; col. 1, lines 55-61) comprising the step of adding a foam control agent to a wastewater treatment process, wherein the foam control agent comprises a branched alcohol that has the structure of: PNG media_image1.png 92 195 media_image1.png Greyscale wherein x is an integer from 2 to 8 and R is an alkyl group with 1 - 8 carbon atoms, wherein the alcohol has from 9 to 12 carbon atoms (column 1, lines 5-9, 34-44; column 5, lines 1-14; column 6, lines 51-68). Therefore, Abel discloses the claimed invention, except for a silicone. However, Abel notes that silicone oil is a traditional defoamer (Abel, col. 10, lines 3-7). Also, Chen more broadly discloses the same or similar foam agent, and methods for controlling foam ([0006]) and demonstrates its application in the food industry ([0002]-[0006]; claim 1). Although not specific to wastewater, Chen also notes the widespread use of silicone materials or silicone-based agent as a stand-alone foam control agent or to supplement foam control ([0001], [0017], claims 9 and 14). As such, at the time of the effective filing of the claimed invention, it would have been obvious to add a silicone to assist in the defoaming process since it is well known that silicone is effective for foam control or as a supplement to other methods of foam control in diverse environments. Additional Disclosure Included: Claim 6:In the method, at least one other foam control agent or hydrophobic material is added (Abel, column 1, lines 34-44; column 6, lines 51-68; Chen, [0017]). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the claims at issue are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 5 and 6 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 5-7 and 9 of copending Application No. 18/248879. Although the claims at issue are not identical, they are not patentably distinct from each other because the applications recite the same or similar limitations relating to controlling foam using a foam agent comprising a branched alcohol with a specified structure that contains an alkyl group and a specified range of carbon atoms. The applications recite different uses of the foam control agent but the underlying control agent appears to be the same and the application methods or steps are straightforward in that they only requires use of the agent. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. Response to Arguments Applicant’s arguments filed 08-22-2025 have been fully considered. In view of the claim amendments, Examiner has modified and attempted to clarify the rejections. Regarding Chen, in this OA, Examiner uses this to supplement Abel and not as a primary reference. With respect to Applicant argument regarding the synergistic effect of silicone, while this may be true, this by itself does not overcome the strong obviousness rationale for adding silicone to another foam control agent. The reference itself need not speak of synergies since it would already be obvious to add the silicone, even if the result is ultimately surprising. Examiner recognizes that obviousness may be established by combining or modifying the teachings of the prior art to produce the claimed invention where there is some teaching, suggestion, or motivation to do so found either in the references themselves or in the knowledge generally available to one of ordinary skill in the art. See In re Fine, 837 F.2d 1071, 5 USPQ2d 1596 (Fed. Cir. 1988), In re Jones, 958 F.2d 347, 21 USPQ2d 1941 (Fed. Cir. 1992), and KSR International Co. v. Teleflex, Inc., 550 U.S. 398, 82 USPQ2d 1385 (2007). In this case, each of the references themselves suggest the combination. The fact that the inventor may have recognized another advantage which would flow naturally from following the suggestion of the prior art cannot be the basis for patentability when the differences between the prior art and the claimed invention would otherwise be obvious. See Ex parte Obiaya, 227 USPQ 58, 60 (Bd. Pat. App. & Inter. 1985). With respect to the amended claims, Examiner has added additional or clarified rationales with respect to any new or added/amended limitations. As such, Examiner believes all claim limitations as well as each of Applicant’s relevant arguments are fully and properly addressed either in this section or in the modified patentability analysis above. While Examiner appreciates Applicant’s efforts to expedite prosecution of the Application, for the stated reasons, Examiner believes the claims are not presently in condition for allowance. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Electronic Inquiries Any inquiry concerning this communication or an earlier communications from the examiner should be directed to Hayden Brewster whose telephone number is (571)270-1065. The examiner can normally be reached M-Th 9 AM - 4 PM. Alternatively, to contact the examiner, Applicant may send a communication, via e-mail or fax. Examiner’s direct fax number is: (571) 270-2065. Examiner's official e-mail address is: "Hayden.Brewster@uspto.gov." However, since e-mail communication may not be secure, Examiner will not respond to a substantive e-mail unless Applicant’s communication is in accordance with the provisions of MPEP §502.03 & related sections that discuss the required Authorization for Internet Communication (AIC). Nonetheless, all substantive communications will be made of record in Applicant’s file. To facilitate the Internet communication authorization process, Applicant may file an appropriate letter, or may complete the USPTO SB439 fillable form available at https://www.uspto.gov/sites/default/files/documents/sb0439.pdf, preferably in advance of any substantive e-mail communication. Since one may use an electronic signature with this particular form, Applicant is encouraged to file this form via the Office’s system for electronic filing of patent correspondence (i.e., the electronic filing system (Patent Center)). Otherwise, a handwritten signature is required. In addition to Patent Center, Applicant can submit their Internet authorization request via US Postal Service, USPTO Customer Service Window, or Central Fax. Examiner can also provide a one-time oral authorization, but this will only apply to video conferencing. It is improper to request Internet Authorization via e-mail. Examiner interviews are available via telephone, in-person, and via video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, Applicant is encouraged to use the USPTO Automated Interview Request (AIR) form available at http://www.uspto.gov/interviewpractice, or Applicant may call Examiner, if preferable. Applicant can access a general list of patent application forms at either https://www.uspto.gov/patent/forms/forms-patent-applications-filed-or-after-september-16-2012 (applications filed on or after September 16, 2012) or https://www.uspto.gov/patent/forms/forms (applications filed before September 16, 2012). Note that the language in an AIR form is not a substitute for the requirements of an AIC, where appropriate. The mere filing of an Applicant Initiated Interview Request Form (PTOL-413A) or a Letter Requesting Interview with Examiner, in EFS-Web, may not apprise Examiner of such a request in a timely manner. If attempts to reach the Examiner are unsuccessful, Applicant may reach Examiner’s supervisor, Bobby Ramdhanie at 571-270-3240. The central fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HAYDEN BREWSTER/Examiner, AU 1779 'No Matter Where You Come from, So Long as You Are a Black Man [Woman], You Are an African' -- Peter Tosh.'No Matter Where You Come from, So Long as You Are a Black Man [Woman], You Are an African' -- Peter Tosh.
Read full office action

Prosecution Timeline

Apr 13, 2023
Application Filed
Jun 14, 2025
Non-Final Rejection — §103, §DP
Aug 22, 2025
Response Filed
Apr 04, 2026
Final Rejection — §103, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12589340
Rotary filter and associated filtering method
2y 5m to grant Granted Mar 31, 2026
Patent 12590016
FILTERING CONTAINER FOR LIQUIDS
2y 5m to grant Granted Mar 31, 2026
Patent 12583953
Method for Separating Polyisoprene and Other Apolar Valuable Substances from Vegetable Feedstock
2y 5m to grant Granted Mar 24, 2026
Patent 12577137
PROCESS FOR WATER TREATMENT USING IMMERSED GAS TRANSFER MEMBRANES
2y 5m to grant Granted Mar 17, 2026
Patent 12565635
Method Of Operation of a Perfusion System
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
61%
Grant Probability
99%
With Interview (+50.4%)
3y 6m
Median Time to Grant
Moderate
PTA Risk
Based on 534 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month